According to the “Sunday Telegraph” report, if approved, the Oxford COVID-19 vaccine will be distributed in the UK from January 4.
The British government has set a goal of vaccinating 2 million people within two weeks of starting the distribution.
According to The Telegraph, the plan includes doses of the Oxford-AstraZeneca vaccine or Pfizer-BioNTech vaccine.
The Oxford vaccine is expected to be approved by the British Medicines and Healthcare Administration in the next few days.
The first trials of the Oxford vaccine found that it was less effective than the approved Pfizer and Moderna vaccines, which have reported efficiencies of 95% and 94.5%, respectively.
In the case of agreeing to pay 2,000 dollars, Sanders called for the relief bill “CRUEL” to delay payment
Pascal Soriot, CEO of AstraZeneca, has increased hopes for the vaccine and promised to publish a paper describing how the vaccine uses two doses.
Soriot said in an interview with The Sunday Times: “We think we have figured out the magic weapon to win and how to obtain effective effects. After two doses, everyone else can use it.”
However, the Ministry of Health said it must give regulators some time to review the results of Oxford vaccines.
A health ministry spokesperson told Reuters: “We must now give MHRA time to do its important work, and we must wait for its recommendations.”
The number of people hospitalized nationwide is increasing, partly because a variant is reported to spread 70% faster than the previous coronavirus.
Click here for the FOX News App
In the leaked memo, NHS medical director Steve Powis ordered the hospital to be highly vigilant against new mutations and South African strains.